Postmenopausal breast cancer: European challenge and innovative concepts
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
28824739
PubMed Central
PMC5545986
DOI
10.1007/s13167-017-0094-6
PII: 94
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiovascular component, Diabetes, Drug sensitivity, Flammer syndrome, Metastatic disease, Pain, Patient stratification, Postmenopausal breast cancer, Predictive preventive and personalised medicine, Risk factors, Systemic hypoxia, “Seed and soil” theory,
- Publikační typ
- časopisecké články MeSH
Breast cancer (BC) epidemic is recognised now worldwide as the reality of the early twenty-first century. Increasing trends in the postmenopausal BC prevalence, even for the European countries earlier demonstrating relatively stable incidence rates of the disease, are highly alarming for the healthcare givers. This new actuality requires a substantial revision of the paradigm currently applied to the BC management and creation of highly innovative concepts. Current multi-centred study highlights new complex mechanisms of the development and progression of the postmenopausal BC. Innovative concepts are presented which argue for more effective predictive and preventive approaches well justified in view of the clusters of the symptoms analysed here and demonstrated as highly prevalent in the postmenopausal breast cancer versus BC-free individuals. Another conceptual novelty presented here is a new interpretation of the "Seed and Soil" theory of metastasis in BC. According to the new concept, the "pre-metastatic niches" ("Soil") are created by a systemic hypoxia a long time before the breast malignancy is clinically manifested.
Breast Cancer Research Centre Rheinische Friedrich Wilhelms University of Bonn Bonn Germany
Department of Neurology Faculty Hospital Plzen Plzen Czech Republic
Department of Ophthalmology University of Basel Basel Switzerland
Diabetes and Metabolic Disorders University Clinic of Endocrinology Skopje Macedonia
European Medical Association EMA Brussels Belgium
Faculty of Medical Sciences University Goce Delcev Stip Stip Macedonia
University Clinic of Radiotherapy and Oncology Skopje Macedonia
Zobrazit více v PubMed
Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V, Grech G. Breast cancer epidemic in the early 21st century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biol. 2016;37(10):12941–12957. doi: 10.1007/s13277-016-5168-x. PubMed DOI
Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, Renehan AG, Forman D, Soerjomataram I. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European cancer observatory. Eur J Cancer. 2015;51(9):1164–1187. doi: 10.1016/j.ejca.2013.09.002. PubMed DOI
Golubnitschaja O. Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J 2017; 8(1):17–22. doi:10.1007/s13167-017-0086-6. PubMed PMC
Zubor P, Gondova A, Polivka J, Jr, Kasajova P, Konieczka K, Danko J, Golubnitschaja O. Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J. 2017 PubMed PMC
Bubnov R, Polivka J, Jr, Zubor P, Koniczka K, Golubnitschaja O. “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer syndrome” relevance to address the question. EPMA J. 2017 PubMed PMC
Kokolus K, Hing CC, Repasky EA. Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperth. 2010;26(7):662–680. doi: 10.3109/02656736.2010.507235. PubMed DOI PMC
Daniels LB, Maisel AS. Cardiovascular biomarkers and sex: the case for women. Nat Rev Cardiol. 2015;12(10):588–596. doi: 10.1038/nrcardio.2015.105. PubMed DOI
Golubnitschaja O, Debald M, Kuhn W, Yeghiazaryan K, Bubnov RV, Goncharenko VM, Lushchyk U, Grech G, Konieczka K. Flammer syndrome and potential formation of pre-metastatic niches: a multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease. EPMA J. 2016;7(Suppl 1):9.
Cox TR, Rumney RM, Schoof EM, Perryman L, Hoye AM, Agrawal A, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015;522:106–110. doi: 10.1038/nature14492. PubMed DOI PMC
Vanharanta S. A hypoxic ticket to the bone metastatic niche. Breast Cancer Res. 2015;17(1):122. doi: 10.1186/s13058-015-0635-7. PubMed DOI PMC
Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T, Kurysheva N, Yao K. Flammer syndrome. EPMA J. 2014;5(1):11. doi: 10.1186/1878-5085-5-11. PubMed DOI PMC
Yeghiazaryan K, Flammer J, Orgül S, Wunderlich K, Golubnitschaja O. Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes. Mol Vis. 2009;15:2339–2348. PubMed PMC
Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013;4(1):14. doi: 10.1186/1878-5085-4-14. PubMed DOI PMC
Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J. 2010;1(2):263–272. doi: 10.1007/s13167-010-0032-3. PubMed DOI PMC
Golubnitschaja O, Yeghiazaryan K, Flammer J. Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible? EPMA J. 2010;1(2):237–244. doi: 10.1007/s13167-010-0031-4. PubMed DOI PMC
Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J. 2013;4(1):6. doi: 10.1186/1878-5085-4-6. PubMed DOI PMC
Konieczka K, Choi HJ, Koch S, Schoetzau A, Küenzi D, Kim DM. Frequency of symptoms and signs of primary vascular dysregulation in Swiss and Korean populations. Klin Monatsbl Augenheilkd. 2014;231(4):344–347. doi: 10.1055/s-0034-1368239. PubMed DOI
Konieczka K, Fränkl S. Primäre vaskuläre Dysregulation und Glaukom (Primary vascular dysregulation and glaucoma) Z prakt Augenheilkd. 2013;34:207–215.
Konieczka K, Koch S, Binggeli T, Schoetzau A, Kesselring J. Multiple sclerosis and primary vascular dysregulation (Flammer syndrome) EPMA J. 2016;7:13. doi: 10.1186/s13167-016-0062-6. PubMed DOI PMC
Konieczka K, Koch S, Schoetzau A, Todorova MG. Increased prevalence of Flammer syndrome in patients with retinitis Pigmentosa. Klin Monatsbl Augenheilkd. 2016;233(4):448–452. doi: 10.1055/s-0041-111802. PubMed DOI
Konieczka K, Todorova MG, Chackathayil TN, Henrich PB. Cilioretinal artery occlusion in a young patient with flammer syndrome and increased retinal venous pressure. Klin Monatsbl Augenheilkd. 2015;232(4):576–578. doi: 10.1055/s-0035-1545774. PubMed DOI
Konieczka K, Flammer J, Sternbuch J, Binggeli T, Fraenkl S. Leber’s hereditary optic neuropathy, normal tension glaucoma, and Flammer syndrome: long term follow-up of a patient. Klin Monatsbl Augenheilkd. 2017 PubMed
Health Consumer Powerhouse. Eurohealth Consumer Index Report, 2014. Taby, Sweden: Health Consumer Powerhouse. http://www.healthpowerhouse.com/files/EHCI_2014/EHCI_2014_report.pdf. Accessed on 22 Jan 2017.
Smokovski I, Milenkovic T, Trapp C, Mitov A. Diabetes Care in Republic of Macedonia: challenges and opportunities. Annals of Global Health. 2015;81(6):792–802. doi: 10.1016/j.aogh.2015.12.017. PubMed DOI
Ministry of Health of Republic of Macedonia. National guidelines for medical care of breast cancer, 2015. http://zdravstvo.gov.mk/wp-content/uploads/2015/08/Rak-na-dojka.pdf. Accessed on 22 Jan 2017.
Gershan V, Antevska-Grujoska S. Performance of mammography equipment in the Macedonian breast screening campaign 2008/2009. Radiat Prot Dosim. 2011;147(1–2):187–191. doi: 10.1093/rpd/ncr290. PubMed DOI
Gjorgov NA. Breast cancer risk assessments to barrier contraception exposure. A new approach. Prilozi. 2009;30(1):217–232. PubMed
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–814. doi: 10.1001/jama.2014.732. PubMed DOI PMC
Overweight and obesity—BMI statistics [database on the Internet]. Eurostat. http://ec.europa.eu/eurostat/statistics-explained/index.php/Overweight_and_obesity_-_BMI_statistics Accessed on 28 March 2017.
Arnold M, Freisling H, Stolzenberg-Solomon R, Kee F, O'Doherty MG, Ordóñez-Mena JM, Wilsgaard T, May AM, Bueno-de-Mesquita HB, Tjønneland A, Orfanos P, Trichopoulou A, Boffetta P, Bray F, Jenab M, Soerjomataram I, CHANCES consortium Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol. 2016;31(9):893–904. doi: 10.1007/s10654-016-0169-z. PubMed DOI PMC
Horn-Ross PL, Canchola AJ, Bernstein L, Neuhausen SL, Nelson DO, Reynolds P. Lifetime body size and estrogen-receptor-positive breast cancer risk in the California teachers study cohort. Breast Cancer Res. 2016;18(1):132. doi: 10.1186/s13058-016-0790-5. PubMed DOI PMC
Rosner B, Eliassen AH, Toriola AT, Chen WY, Hankinson SE, Willett WC, Berkey CS, Colditz GA. Weight and weight changes in early adulthood and later breast cancer risk. Int J Cancer. 2017;140(9):2003–2014. doi: 10.1002/ijc.30627. PubMed DOI PMC
Cebioglu M, Schild HH, Golubnitschaja O. Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures. EPMA J. 2010;1(1):130–137. doi: 10.1007/s13167-010-0015-4. PubMed DOI PMC
Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomark Prev. 2008;17(11):3116–3122. doi: 10.1158/1055-9965.EPI-08-0527. PubMed DOI PMC
Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, Michael Y, O’Sullivan MJ, Stefanick ML, Prentice R. Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010;28(6):1005–1010. doi: 10.1200/JCO.2009.25.0423. PubMed DOI PMC
Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med. 2013;274(2):113–126. doi: 10.1111/joim.12084. PubMed DOI PMC